Search
Abeona Therapeutics Inc
ABEOAdd to Watchlist
6.420USD
-0.050-0.77%
Close 07-31 16:00（ET）Quotes delayed by 15 min
365.91MMarket Cap
5.00P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Abeona Therapeutics Inc is 9.00, ranking 4 out of 155 in the Pharmaceuticals industry. The average price target is 19.00, with a high of 27.50 and a low of 14.00.
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
19.714
Target Price
+207.08%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Abeona Therapeutics Inc
ABEO
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Abeona Therapeutics Inc's expected revenue for the next quarter?
Abeona Therapeutics Inc's expected revenue is 12.24M.
What is Abeona Therapeutics Inc's price target?
Analysts forecast that Abeona Therapeutics Inc's price target is USD 19.00, with the highest forecast at USD 27.50 and the lowest forecast at USD 14.00.
How have Abeona Therapeutics IncABEO's recent earnings per share performed?
The market expectation was USD -0.30, while Abeona Therapeutics IncABEO's earnings per share (EPS) for the previous quarter was USD -0.37. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Abeona Therapeutics Inc?
Based on the ratings of Abeona Therapeutics Inc's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.